Davis Bradley R, Yoo Andrew C, Moore Matt, Gunnarsson Candace
Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.
Medical Affairs, Ethicon Endo-Surgery, Cincinnati, OH, USA.
JSLS. 2014 Apr-Jun;18(2):211-24. doi: 10.4293/108680813X13753907291035.
Laparoscopic colectomies, with and without robotic assistance, are performed to treat both benign and malignant colonic disease. This study compared clinical and economic outcomes for laparoscopic colectomy procedures with and without robotic assistance.
Patients aged ≥18 years having primary inpatient laparoscopic colectomy procedures (cecectomy, right hemicolectomy, left hemicolectomy, and sigmoidectomy) identified by International Classification of Diseases, Ninth Edition procedure codes performed between 2009 and the second quarter of 2011 from the Premier Hospital Database were studied. Patients were matched to a control cohort using propensity scores for disease, comorbidities, and hospital characteristics and were matched 1:1 for specific colectomy procedure. The outcomes of interest were hospital cost of laparoscopic robotic-assisted colectomy compared with traditional laparoscopic colectomy, surgery time, adverse events, and length of stay.
Of 25,758 laparoscopic colectomies identified, 98% were performed without robotic assistance and 2% were performed with robotic assistance. After matching, 1066 patients remained, 533 in each group. Lengths of stay were not significantly different between the matched cohorts, nor were rates of major, minor, and/or surgical complications. Inpatient procedures with robotic assistance were significantly more costly than those without robotic assistance ($17,445 vs $15,448, P = .001). Operative times were significantly longer for robotic-assisted procedures (4.37 hours vs 3.34 hours, P < .001).
Segmental colectomies can be performed safely by either laparoscopic or robotic-assisted methods. Increased per-case hospital costs for robotic-assisted procedures and prolonged operative times suggest that further investigation is warranted when considering robotic technology for routine laparoscopic colectomies.
腹腔镜结肠切除术,无论有无机器人辅助,均可用于治疗良性和恶性结肠疾病。本研究比较了有机器人辅助和无机器人辅助的腹腔镜结肠切除术的临床和经济结果。
研究对象为年龄≥18岁、因原发性住院接受腹腔镜结肠切除术(盲肠切除术、右半结肠切除术、左半结肠切除术和乙状结肠切除术)的患者,这些患者由国际疾病分类第九版手术编码确定,数据来源于2009年至2011年第二季度Premier医院数据库。利用疾病、合并症和医院特征的倾向得分将患者与对照组进行匹配,并针对特定结肠切除术按1:1进行匹配。感兴趣的结果包括机器人辅助腹腔镜结肠切除术与传统腹腔镜结肠切除术的住院费用、手术时间、不良事件和住院时间。
在确定的25758例腹腔镜结肠切除术中,98%的手术无机器人辅助,2%的手术有机器人辅助。匹配后,每组各有533例患者,共1066例。匹配队列之间的住院时间、主要、次要和/或手术并发症发生率无显著差异。有机器人辅助的住院手术费用显著高于无机器人辅助的手术(17445美元对15448美元,P = 0.001)。机器人辅助手术的手术时间显著更长(4.37小时对3.34小时,P < 0.001)。
腹腔镜或机器人辅助方法均可安全地进行节段性结肠切除术。机器人辅助手术的每例住院费用增加和手术时间延长表明,在考虑将机器人技术用于常规腹腔镜结肠切除术时,有必要进行进一步研究。